BN Business News
Add your company to Business Communicator →

Technology · 19/11/20261 min read

Harbour BioMed Announces NMPA Acceptance of IND Application for Its First AI-Enabled Drug Candidate LET003 for the Treatment of Overweight or Obesity

EDITORIAL ILLUSTRATIONTTechnologyBN
Illustration generated by Business News; it is not a source photograph.

Summary

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Nov. 18, 2026 — Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →